Our previous studies showed that the treatment of breast cancer cells with TNF-α resulted in upregulation of CDKN1A/p21-dependent MMP9 expression/secretion which was found to be essential for cell migration [17,34]. This evidence concerns the gene CDKN1A and breast cancer.